Everence Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$512K Hold
820
– – 0.03% 392
2026
Q2
$434K Hold
820
– – 0.02% 468
2026
Q1
$394K Hold
820
– – 0.02% 454
2025
Q4
$461K Hold
820
– – 0.03% 418
2025
Q3
$422K Hold
820
– – 0.03% 456
2025
Q2
$257K Hold
820
– – 0.02% 647
2025
Q1
$250K Hold
820
– – 0.02% 650
2024
Q4
$272K Buy
+820
New +$278K 0.02% 628
2020
Q3
– Sell
-5,530
Closed -$513K – 716
2020
Q2
$513K Hold
5,530
– – 0.06% 285
2020
Q1
$406K Hold
5,530
– – 0.06% 291
2019
Q4
$465K Hold
5,530
– – 0.07% 304
2019
Q3
$465K Hold
5,530
– – 0.08% 287
2019
Q2
$362K Hold
5,530
– – 0.06% 363
2019
Q1
$326K Buy
+5,530
New +$330K 0.06% 380

Other funds holding MEDP

Everence Capital Management's MEDP Position: Q3 2026 in Review

Everence Capital Management held its Medpace (MEDP) position steady in Q3 2026 at 820 shares worth $512K. The position accounts for 0.03% of the portfolio, ranked #392.

Everence Capital Management first reported a position in MEDP in Q1 2019 and has held it in 14 quarters since. The position peaked at $513K in Q2 2020. 755 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Everence Capital Management held 820 shares of Medpace worth $512K as of Q3 2026.
  • Everence Capital Management left its Medpace share count unchanged in Q3 2026.
  • Medpace made up 0.03% of Everence Capital Management's portfolio in Q3 2026, its #392 holding.
  • Everence Capital Management first reported a position in Medpace in Q1 2019 and has held it in 14 quarters since.
  • Everence Capital Management's Medpace position peaked at $513K in Q2 2020.
  • 755 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.